Skip to main content
Loading

New formats / chemical modifications for antisense therapeutics (Topic TBC)

30 Oct 2024
New Modalities
Industry Experts
Weiguo Zhai, Senior Director, R&D Analytical Sciences, BioPharmaceutical Development - AstraZeneca